Related Experiment Videos

Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal)

Lancet (London, England)
|November 15, 1986
PubMed

Insights

A hepatitis B vaccine booster provides significant protection against infection for children. However, efficacy wanes after 4 years, suggesting a need for a second booster 5 years post-initial dose.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Hepatitis B infection poses a significant global health risk, particularly in pediatric populations.
  • Long-term vaccine efficacy and the need for booster doses are critical considerations for sustained hepatitis B prevention.

Purpose of the Study:

  • To evaluate the long-term protective efficacy of a hepatitis B vaccine booster dose in children.
  • To determine the optimal timing for subsequent booster vaccinations to maintain immunity.

Main Methods:

  • A cohort of 143 children received a hepatitis B vaccine booster dose one year after initial vaccination.
  • Hepatitis B incidence was monitored over six years and compared to a similar unvaccinated control group.

Main Results:

  • The booster dose demonstrated a significant reduction in hepatitis B incidence (1.5% per year) compared to unvaccinated children (11.5% per year).
  • Vaccine efficacy remained at 100% for the first four years but declined to 67% by the fifth and sixth years.

Conclusions:

  • A single hepatitis B vaccine booster provides substantial, albeit time-limited, protection in children.
  • A second booster dose approximately five years after the initial booster is recommended to ensure sustained immunity and maximum protection against hepatitis B.

Related Concept Videos